Heartfelt Tech sees a 53% reduction in recurrent heart failure events

Wed, Oct 14, 2026

The HF-TRACK results are in. Professor John Cleland presented the final results of Heartfelt’s UK randomised HF-TRACK trial at the Heart Failure Society of America meeting in Phoenix.

The key finding: a 53% reduction in recurrent heart failure events with Heartfelt-supported care compared with standard care (HR 0.47; p=0.052).

What makes this particularly exciting is that the technology requires no active patient engagement. No daily measurements to remember, no devices to wear, and no additional tasks for patients.

Read more here.